期刊文献+

2890株鲍曼不动杆菌的分布特征及耐药谱变迁 被引量:7

Distribution and drug resistance of 2890 strains of Acinetobacter baumannii
原文传递
导出
摘要 目的探讨鲍曼不动杆菌的分布特征及耐药性的变迁,为临床治疗提供参考。方法回顾性分析2002年至2011年湖州市中心医院各类临床标本分离出的鲍曼不动杆菌检出率、分布特点及药敏结果。结果 10年共检出鲍曼不动杆菌2 890株,分离率为4.9%。来源以痰液为主,占84.3%。科室分布以重症监护室、呼吸内科、脑外科为主。鲍曼不动杆菌对替卡西林、替卡西林/棒酸、哌拉西林和氨苄西林/舒巴坦的耐药率最为严重,并逐年上升;对头孢他啶等10种抗菌药物耐药率也逐年上升,但对头孢哌酮/舒巴坦和多粘菌素E敏感性均良好。结论鲍曼不动杆菌的分离率和耐药性均呈上升趋势,应重视对该菌耐药性的监测,合理使用抗菌药物,同时加强院感控制,防止耐药菌株播散。 Objective To investigate the characteristic of distribution and the change in drug resistance of Acinetobacter baumannii,provide reference for clinical treatment.Methods The distribution and drug resistance of Acinetobacter baumannii isolated from various clinical specimens of the infectious patients in Huzhou Central Hospital from 2002 to 2011 were retrospectively analyzed and studied.Results A total of 2 890 strains of Acinetobacter baumannii were isolated during investigate period and the isolation rate was 4.9%.Sputum was the main specimen from which 84.3% strains of Acinetobacter baumannii were isolated.Acinetobacter baumannii were mainly distributed at ICU wards,pneumology department and neurosurgery department.The resistance rates to ticarcillin,ticarcillin/clavulanic acid,piperacillin and ampicillin/sulbactam were very high and appeared an increasing trend during investigate period.The resistance rates to other ten antibiotics were also increasing year by year.But to cefoperazone/sulbactam and polymyxin during investigate period,they were all sensitive.Conclusion The isolation rate and drug resistance of Acinetobacter baumannii are increasing,it is necessary for hospital to attach importance to the monitoring of its drug resistance,choose the antibiotics rationally and strengthen control the hospital infection,so as to prevent the spread of its multidrug-resistant strains.
出处 《中国微生态学杂志》 CAS CSCD 2013年第1期65-66,69,共3页 Chinese Journal of Microecology
关键词 鲍曼不动杆菌 分布 抗菌药物 耐药性 Acinetobacter baumannii Distribution Antibiotics Drug resistance
  • 相关文献

参考文献7

  • 1叶应妩;王毓三;申子瑜.全国临床检验操作规程[M]南京:东南大学出版社,2006770.
  • 2MUNOZ-PRICE L S,WEINSTEIN R A. Acinetobacter[J].New England Journal of Medicine,2008,(12):1271-1281.
  • 3汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,简翠,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华.2008年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2009,9(5):321-329. 被引量:422
  • 4汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,李丽,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华,徐元宏,沈继录,单斌,杜艳.2009年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2010,10(5):325-334. 被引量:397
  • 5朱德妹,汪复,胡付品,蒋晓飞,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,陈中举,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,王爱敏,张泓,孔菁,徐元宏,沈继录,单斌,杜艳.2010年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2011,11(5):321-329. 被引量:651
  • 6池琼,郑纪阳,戴新建,陈身贤,徐克.2005~2008年鲍氏不动杆菌的耐药性变迁分析[J].中华医院感染学杂志,2010,20(8):1163-1165. 被引量:19
  • 7董晓勤,周田美,沈强,范建中,汪涛.2001~2008年鲍曼不动杆菌的耐药变迁[J].中国卫生检验杂志,2010,20(3):610-612. 被引量:16

二级参考文献48

  • 1曹海燕.4a间鲍曼不动杆菌临床分析特点及耐药变迁[J].实用医技杂志,2006,13(2):208-209. 被引量:5
  • 2王辉,郭萍,孙宏莉,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.碳青霉烯类耐药的不动杆菌分子流行病学及其泛耐药的分子机制[J].中华检验医学杂志,2006,29(12):1066-1073. 被引量:237
  • 3Clinical and I.aboratory Standards Institute(CLSI). Perform ance standards for Antimicrobial susceptibility testing[S]. M100-S17, 2007.
  • 4Clinical and Laboratory Standards Institute (CLSI). Perform anee standards for Antimicrobial susceptibility testing [S]. M100-S19,2009.
  • 5Bratu S, I.andman D, Haag R, et al. Rapid spread of carbapenem resistant Klebsiella pneumoniae in New York City: anew threat to our antibiotic armamentarium[J]. Arch Int Meal.2005,165(12) :1430-1435.
  • 6Endimiani A, Hujer AM, Perez F, et al. Characterization of blaKPC containing Klebsiella pneumoniae isolates detected in different institutions in the eastern USA [J]. J Antimierob Chemother, 2009, 63(3):427-437.
  • 7Jeon BC, Jeong SH, Bae IK, et al. Investigation of a nosocomial outbreak of imipenem resistant Acinetobacter baumannii producing the OXA- 23 β- lactamase in Korea[J]. J Clin Microbiol, 2005, 43(5):2241 -2245.
  • 8NaasT, LevyM, HirschauerC, et al. Outbreak ofcarbapen em resistant Acinetobacter baumannii producing the carbap enemase OXA- 23 in a tertiary care hospital of Pepcete, French Polynesta[J]. J Clin Mierohiol, 2005, 43 (9) : 4826- 4829.
  • 9Waites KB, Dully LB, Dowzicky MJ. Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and invitro activity of tigecycline, a new glycylcycline antimicrobial[J]. Antimicrob Agents Chemother, 2006,50(10):3479- 3484.
  • 10Souli M, Kontopidou FV, Koratzanis E, et al. lnvitro activity of tigecycline against multiple-drug resistant, including pan resistant, Gram negative and Gram-positive clinical isolates from Greek hospitals[J]. Antimicrob Agents Chemother, 2006.50(9) :3166- 3169.

共引文献1338

同被引文献70

  • 1侯盼飞,应春妹,汪雅萍,叶杨芹,张灏旻.耐碳青霉烯类抗生素鲍曼不动杆菌产β内酰胺酶研究[J].中国感染与化疗杂志,2010,10(4):285-289. 被引量:25
  • 2王虹,贾海琴,燕成岭,曹银芳.2010—2011年多重耐药菌的调查分析[J].内蒙古医科大学学报,2012,34(S2):194-197. 被引量:2
  • 3曹弟勇,周歧新,凌保东.洋葱伯克霍尔德菌及其耐药现状[J].国外医药(抗生素分册),2006,27(6):272-275. 被引量:11
  • 4.医院感染诊断标准(试行)[S].[S].中华人民共和国卫生部,2001.2..
  • 5Quale J,Bratu S,Landman D,et al.Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin Infect Dis,2003,37(2) : 214-220.
  • 6Robicsek A,Jacoby GA,Hooper DC.The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis,2006,6(10) : 629-640.
  • 7潘玲.痰热清注射液佐治鲍氏不动杆菌肺炎疗效观察.辽宁中医药人学学报,2013,15(3):193-195.
  • 8Clinical and Laboratory Standard Institute.M07-A8 Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically;approved standard-eighth edition[S].2012.
  • 9CLSI. M07/A8-2013. Performance standards for antimicrobial sus- ceptibility testing[ S~. America: Clinical and Laboratory Standards Institute, 2013.
  • 10Peleg AY,Seifert H,Paterson DL.Acinetobacter baumannii:emergence of a successful pathogen[J].Clin Microbiol Rev,2008,21(3):538-582.

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部